Arthneeti

Aspira Pathlab & Diagnostics Share Price & Earnings Call Analysis

₹137.55+5.00% today
Market cap
₹142 Cr
ROE
0.69%
Price to sales
5.47
Debt to equity
1.13
52W high / low
₹143 / ₹54.0
Sales growth (5Y)
10.43%
EBITDA margin
3.82%
Net profit margin
0.20%
Promoter holding
46.65%
Sales (last year)
₹26 Cr

Potential multibaggers · Q2 FY27

This quarter's potential multibaggers
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Aspira Pathlab rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Financials of Aspira Pathlab

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Aspira Pathlab

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +3.412.603.323.463.824.646.185.415.785.258.095.126.52
Expenses +3.262.923.683.833.954.294.834.654.734.445.906.336.85
Operating Profit0.15-0.32-0.36-0.37-0.130.351.350.761.050.812.19-1.21-0.33
OPM %4.40%-12.31%-10.84%-10.69%-3.40%7.54%21.84%14.05%18.17%15.43%27.07%-23.63%-5.06%
Other Income +0.070.100.140.100.080.090.080.090.130.110.140.130.14
Interest0.100.100.100.090.080.080.080.090.090.090.100.100.10
Depreciation0.380.390.390.380.380.380.360.390.370.370.400.380.40
Profit before tax-0.26-0.71-0.71-0.74-0.51-0.020.990.370.720.461.83-1.56-0.69
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.26-0.72-0.71-0.74-0.50-0.020.990.380.720.471.84-1.56-0.69
EPS in Rs-0.25-0.70-0.69-0.72-0.49-0.020.960.370.700.461.79-1.52-0.67

Financials of Aspira Pathlab

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +0.000.000.764.367.648.4215.2119.5414.4613.2022.0024.98
Expenses +0.140.233.348.2410.8810.2511.6913.1612.8614.3818.4423.52
Operating Profit-0.14-0.23-2.58-3.88-3.24-1.833.526.381.60-1.183.561.46
OPM %-339.47%-88.99%-42.41%-21.73%23.14%32.65%11.07%-8.94%16.18%5.84%
Other Income +0.210.320.310.220.250.290.200.090.320.420.360.52
Interest0.000.050.260.800.961.010.890.370.420.370.350.39
Depreciation0.000.000.201.121.231.661.441.641.591.541.491.54
Profit before tax0.070.04-2.73-5.58-5.18-4.211.394.46-0.09-2.672.080.05
Tax %57.14%25.00%0.00%0.00%0.00%0.71%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +0.020.03-2.72-5.58-5.18-4.241.384.46-0.09-2.672.070.05
EPS in Rs0.090.13-5.24-10.75-6.32-4.561.344.33-0.09-2.592.010.05
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of Aspira Pathlab

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital2.252.255.195.198.199.2910.2910.2910.2910.2910.2910.29
Reserves1.361.390.72-4.86-7.93-10.42-6.91-2.43-2.47-5.08-3.011.94
Borrowings +0.002.627.2911.3612.5213.807.018.858.247.718.133.32
Other Liabilities +0.210.031.660.842.021.671.391.421.281.792.112.96
Total Liabilities3.826.2914.8612.5314.8014.3411.7818.1317.3414.7117.5218.51
Fixed Assets +0.000.047.797.918.908.707.759.578.016.796.537.20
CWIP0.000.000.250.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.130.00
Other Assets +3.826.256.824.625.905.644.038.569.337.9210.8611.31
Total Assets3.826.2914.8612.5314.8014.3411.7818.1317.3414.7117.5218.51

Financials of Aspira Pathlab

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-0.37-1.29-4.81-3.39-1.875.672.03-0.011.051.881.45
Cash from Investing Activity +-0.02-10.14-0.77-1.970.24-0.09-0.510.160.140.07-0.80
Cash from Financing Activity +2.648.916.523.351.27-2.17-1.35-0.94-0.95-0.99-1.14
Net Cash Flow2.25-2.520.94-2.00-0.353.410.17-0.790.240.95-0.49
Free Cash Flow-0.41-8.41-5.81-3.90-1.925.371.42-0.150.791.710.75
CFO/OP139%50%124%105%101%161%32%-1%-89%53%99%

Financials of Aspira Pathlab

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days43.2229.3038.2226.0140.8083.8759.0761.9438.9925.28
Inventory Days312.86103.8845.2251.3651.3546.5058.4062.6950.3156.53
Days Payable730.0064.5846.8473.3791.6070.9151.10101.7073.0092.06
Cash Conversion Cycle-373.9268.6136.604.000.5559.4666.3722.9316.30-10.25
Working Capital Days-2,199.61-5.86-96.03-127.0116.3269.3048.7225.1614.10-4.24
ROCE %1.82%-25.39%-38.41%-34.49%-25.15%19.77%35.65%2.01%-15.87%17.37%2.84%